Connors Investor Services’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,345
Closed -$207K 161
2023
Q2
$207K Sell
4,345
-3,285
-43% -$148K 0.02% 146
2023
Q1
$300K Sell
7,630
-570
-7% -$20.7K 0.04% 122
2022
Q4
$232K Hold
8,200
0.03% 134
2022
Q3
$246K Hold
8,200
0.03% 124
2022
Q2
$278K Hold
8,200
0.04% 120
2022
Q1
$368K Sell
8,200
-500
-6% -$23.1K 0.04% 117
2021
Q4
$402K Sell
8,700
-1,300
-13% -$52.4K 0.04% 117
2021
Q3
$336K Sell
10,000
-409
-4% -$13.9K 0.04% 124
2021
Q2
$306K Hold
10,409
0.03% 126
2021
Q1
$268K Hold
10,409
0.03% 133
2020
Q4
$237K Hold
10,409
0.03% 127
2020
Q3
$223K Hold
10,409
0.03% 119
2020
Q2
$242K Hold
10,409
0.04% 117
2020
Q1
$222K Sell
10,409
-2,362
-18% -$56.2K 0.04% 110
2019
Q4
$299K Hold
12,771
0.04% 113
2019
Q3
$268K Hold
12,771
0.04% 118
2019
Q2
$261K Hold
12,771
0.03% 120
2019
Q1
$359K Hold
12,771
0.05% 105
2018
Q4
$312K Sell
12,771
-2,916
-19% -$78.4K 0.05% 106
2018
Q3
$583K Sell
15,687
-10,813
-41% -$292K 0.08% 97
2018
Q2
$550K Sell
26,500
-6,500
-20% -$115K 0.08% 99
2018
Q1
$475K Hold
33,000
0.07% 100
2017
Q4
$500K Hold
33,000
0.07% 100
2017
Q3
$317K Hold
33,000
0.05% 113
2017
Q2
$284K Buy
33,000
+3,000
+10% +$25.6K 0.04% 121
2017
Q1
$267K Buy
30,000
+10,000
+50% +$92.7K 0.04% 124
2016
Q4
$222K Buy
20,000
+6,000
+43% +$64.6K 0.04% 134
2016
Q3
$238K Buy
14,000
+2,000
+17% +$37K 0.04% 128
2016
Q2
$261K Hold
12,000
0.05% 123
2016
Q1
$230K Buy
12,000
+2,000
+20% +$38.3K 0.05% 131
2015
Q4
$280K Sell
10,000
-9,000
-47% -$254K 0.06% 113
2015
Q3
$463K Hold
19,000
0.1% 98
2015
Q2
$442K Hold
19,000
0.09% 101
2015
Q1
$289K Hold
19,000
0.06% 115
2014
Q4
$245K Buy
19,000
+2,000
+12% +$17.3K 0.06% 122
2014
Q3
$119K Buy
+17,000
New +$154K 0.03% 150

Other funds holding IRMD

Connors Investor Services's IRMD Position: Q3 2023 in Review

Connors Investor Services sold out of iRadimed (IRMD) in Q3 2023, closing a stake of 4,345 shares — an estimated $207K sold.

Connors Investor Services first reported a position in IRMD in Q3 2014 and held it in 36 quarters. The position peaked at $583K in Q3 2018. 113 funds tracked by Wall St. Rank hold IRMD as of Q3 2023.

  • Connors Investor Services reported no remaining iRadimed position as of Q3 2023 after selling out during the quarter.
  • Connors Investor Services sold 4,345 iRadimed shares in Q3 2023, an estimated $207K.
  • Connors Investor Services first reported a position in iRadimed in Q3 2014 and held it in 36 quarters.
  • Connors Investor Services's iRadimed position peaked at $583K in Q3 2018.
  • 113 funds tracked by Wall St. Rank held iRadimed as of Q3 2023.

Based on Connors Investor Services's 13F filing for Q3 2023, filed 22 Nov 2023.